Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes.
Where this comes from
- Record sourced from PubMed, PMID 37532667.
- Also identified by DOI 10.1016/j.pcd.2023.07.005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
Medical subject headings
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Diabetes Mellitus, Type 1
- Cardiovascular Diseases
- Dyslipidemias